Vault-13

SINOVAC BIOTECH LTD SVA

SHS · Common Stock · CUSIP P8696W104

Chinese biopharm company

29 institutional holders -1 vs Q1 2021
22,825,07722.8m shares reported held*
$527.0mreported value*
0 new 1 added 3 reduced 1 sold out net bought ≈ $7.5k (-15.7k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $23.09. Options: 1 managers hold calls ($0 notional), 1 hold puts ($0).

Trends to Q2 2021

Institutional holders

Managers reporting a position, each quarter

0102030Q4 19: 26Q1 20: 25Q2 20: 22Q3 20: 26Q4 20: 28Q1 21: 30Q2 21: 2929Q4 19Q2 20Q4 20Q2 21
Numbers
QuarterHolders
Q4 201926
Q1 202025
Q2 202022
Q3 202026
Q4 202028
Q1 202130
Q2 202129

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
10010Q1 20: 4 bought or addedQ1 20: 6 cut or sold outQ1 20Q2 20: 2 bought or addedQ2 20: 7 cut or sold outQ2 20Q3 20: 4 bought or addedQ3 20: 3 cut or sold outQ3 20Q4 20: 4 bought or addedQ4 20: 3 cut or sold outQ4 20Q1 21: 5 bought or addedQ1 21: 4 cut or sold outQ1 21Q2 21: 1 bought or addedQ2 21: 4 cut or sold outQ2 21
Numbers
QuarterBought or addedCut or sold out
Q1 202046
Q2 202027
Q3 202043
Q4 202043
Q1 202154
Q2 202114

Biggest buyers

MORGAN STANLEY Added +1,341+1.3k

Biggest sellers

Biggest calls

Biggest puts

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
1Globe Capital LLC 13D · may seek influence no change · filed 2025-09-12
Stated purposeItem 4 of the Schedule 13D is hereby amended and supplemented as follows: On July 25, 2025, Vivo Capital Surplus Fund VIII, L.P. ("Vivo Fund VIII") filed an amended complaint (the "Amended Complaint") with the U.S. District Court for the Commonwealth of Massachusetts in the civil action initiated by Vivo Fund VIII on April 14, 2025 and previously disclosed in Amendment No. 6 to the Schedule 13D (the "Vivo Action"). In the Amended Complaint, Vivo Fund VIII alleges a disclosure violation claim under Section 13(d) of the Securities Exchange Act of 1934, repeating in a single count the allegations that appeared in its original complaint. Among other things, Vivo Fund VIII alleges that (1) Dr. Li has not filed a Schedule 13D and as a result investors do not know how many Sinovac shares he be… Full filing
32.3% no change 18.5m 2025-09-12
SAIF Partners IV L.P. 13D · may seek influence no change · filed 2025-12-17 15.0% no change 10.8m 2025-12-17
WEIDONG YIN 13D · may seek influence no change · filed 2025-07-15
Stated purposeItem 4 is hereby amended and supplemented to add the following: The Issuer announced on July 10, 2025 a new board of directors of the Issuer (the "Board"), comprising Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Mr. Chiang Li, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Ms. Rui-Ping Xiao, Mr. Andrew Y Yan (as Chairman of the Board) and the Reporting Person. The Reporting Person has accepted the appointment and plans to participate in the future governance of the Issuer as a member of the newly Board. Except as set forth in this Item 4, the Reporting Person has no present plan or intention that would resu lt in or relate to the listed transactions described in Item 4 of Schedule 13D. The Reporting Person has engaged and will continue to engage in discussions with other shareholders of… Full filing
8.8% no change 6.4m 2025-07-15
Advantech Capital L.P. 13D · may seek influence no change · filed 2025-07-14
Stated purposeItem 4 is hereby supplemented and amended by adding the following: On July 7, 2025, the High Court of Antigua and Barbuda granted an interim injunction prohibiting the Reporting Persons and certain other shareholders from voting their shares at the Special Meeting (the "Injunction Order"). On July 8, 2025, the Court of Appeal of the Eastern Caribbean Supreme Court issued an order staying the Injunction Order (the "Stay Order"). After the Court of Appeal issued the Stay Order, the Special Meeting of Shareholders of the Issuer requisitioned by SAIF Partners IV L.P. ("SAIF") (the "Special Meeting") was convened. Mr. Chiang Li delivered a short statement and then purported to adjourn the Special Meeting. The Reporting Persons understand that the shareholders attending the Special Meeting the… Full filing
8.1% no change 5.9m 2025-07-14
Vivo Capital VIII, LLC 13D · may seek influence no change · filed 2025-07-11
Stated purposeItem 4 is hereby supplemented and amended by adding the following: On May 19, 2025, the Issuer gave notice of a Special Meeting of Shareholders to be held on July 8, 2025 and announced an intention to exclude shares held by the Reporting Persons and another investor from the vote. On May 30, 2025, the Issuer filed an application for an injunction in the High Court of Antigua and Barbuda seeking an order prohibiting the Reporting Persons and the other investor from voting their shares at the Special Meeting. The Reporting Persons have opposed such an injunction in the High Court and the Court of Appeal of the Eastern Caribbean Supreme Court, and, on July 8, 2025, the Court of Appeal issued an order staying execution of an injunction from the High Court. In light of the Court of Appeal's… Full filing
6.3% no change 4.5m 2025-07-11
Vivo Capital IX, LLC 13D · may seek influence filed 2025-03-19
Stated purposeItem 4 is hereby supplemented and amended by adding the following: On February 28, 2025, the Issuer announced a new Board of Directors (the "New Board"). The New Board purportedly does not include Mr. Shan Fu, the Reporting Persons' Board designee since July 2, 2018. Mr. Fu has been excluded from the Issuer's Board of Directors, and requests for his inclusion have gone unanswered. The Reporting Persons intend to take necessary actions to restore Mr. Fu to the Board. The Issuer's announcement also implies that the New Board will take steps to invalidate the July 2, 2018 Private Placement, through which the Reporting Persons acquired the Issuer's common shares and which provided the Issuer with growth capital essential to its subsequent development of the CoronaVac vaccine. The Reporti… Full filing
6.3% 4.5m 2025-03-19

Insider purchases and sales in Q2 2021

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q2 2021.

Holders, Q2 2021

#ManagerLocationShares Value% of their portfolioChangeShares change
1 SAIF Advisors Ltd 92.64% of their portfolio ADMIRALTY, K3 10,780,82010.8m $405.4m $405.4m 92.64% Unchanged
2 Vivo Capital, LLC 1.65% of their portfolio Palo Alto, CA 5,900,0005.9m $38.2m $38.2m 1.65% Unchanged
3 ORBIMED ADVISORS LLC 0.78% of their portfolio New York, NY 2,839,5002.8m $76.8m $76.8m 0.78% Unchanged
4 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 2,375,8412.4m $1.5m $1.5m 0.00% Unchanged
5 Neumann Advisory Hong Kong Ltd 0.33% of their portfolio CENTRAL, K3 315,586315.6k $2.0m $2.0m 0.33% Unchanged
6 STATE STREET CORP 0.00% of their portfolio BOSTON, MA 281,640281.6k $1.8m $1.8m 0.00% Unchanged
7 Yorktown Management & Research Co Inc 0.38% of their portfolio Forest, VA 74,89374.9k $485.0k $485.0k 0.38% Unchanged
8 California Public Employees Retirement System 0.00% of their portfolio Sacramento, CA 68,73268.7k $0 $0 0.00% Unchanged
9 Skandinaviska Enskilda Banken AB (publ) 0.00% of their portfolio STOCKHOLM, V7 40,00040.0k $259.0k $259.0k 0.00% Unchanged
10 Spark Investment Management LLC 0.00% of their portfolio NEW YORK, NY 29,10029.1k $0 $0 0.00% Unchanged
11 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 27,71727.7k $179.0k $179.0k 0.00% Unchanged
12 NAVELLIER & ASSOCIATES INC 0.00% of their portfolio Reno, NV 22,24822.2k $0 $0 0.00% Unchanged
13 Freedom Investment Management, Inc. 0.01% of their portfolio SOUTH WINDSOR, CT 17,87917.9k $116.0k $116.0k 0.01% Reduced -17.0k -17,019
14 SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio BALA CYNWYD, PA 16,43016.4k $106.0k $106.0k 0.00% Unchanged
15 NORTHERN TRUST CORP 0.00% of their portfolio CHICAGO, IL 13,78713.8k $55.0k $55.0k 0.00% Unchanged
16 UBS Group AG 0.00% of their portfolio ZURICH, V8 9,0959.1k $59.0k $59.0k 0.00% Unchanged
17 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 3,8413.8k $25.0k $25.0k 0.00% Added +1.3k +1,341
18 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 3,0003.0k $19.0k $19.0k 0.00% Unchanged
19 WELLS FARGO & COMPANY/MN 0.00% of their portfolio SAN FRANCISCO, CA 1,9121.9k $0 $0 0.00% Reduced -10 -10
20 OSAIC HOLDINGS, INC. 0.00% of their portfolio SCOTTSDALE, AZ 1,3621.4k $0 $0 0.00% Unchanged
21 ROYAL BANK OF CANADA 0.00% of their portfolio TORONTO, A6 431431 $0 $0 0.00% Reduced -9 -9
22 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 424424 $0 $0 0.00% Unchanged
23 GROUP ONE TRADING LLC 0.00% of their portfolio CHICAGO, IL 412412 $3.0k $3.0k 0.00% Unchanged
24 HARBOUR INVESTMENTS, INC. 0.00% of their portfolio MADISON, WI 180180 $1.0k $1.0k 0.00% Unchanged
25 Financial Gravity Asset Management, Inc. 0.00% of their portfolio Lakeway, TX 123123 $6.0k $6.0k 0.00% Unchanged
26 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 106106 $0 $0 0.00% Unchanged
27 NEXT Financial Group, Inc 0.00% of their portfolio HOUSTON, TX 1616 $0 $0 0.00% Unchanged
28 NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.00% of their portfolio MILWAUKEE, WI 22 $0 $0 0.00% Unchanged
29 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged